Guest guest Posted April 8, 2010 Report Share Posted April 8, 2010 I'd like to be hopeful, but I'm still creeped out by that death a few yrs back. Kate f Sent from my iPhone On Apr 8, 2010, at 7:13 AM, <Rheumatoid.Arthritis.Support@...> wrote: Journal of Rheumatology April 2010 Editorial Arthritis Gene Therapy Trials Reach Phase II Arthritis has been on the gene therapy agenda for about 20 years1. Despite its impressive preclinical track record of efficacy and safety in animal models (as reviewed5,6), progress in carrying out clinical trials has been painfully slow4. The literature contains only 2 small Phase I studies3,4 and a report of 2 subjects who experienced symptomatic relief following gene transfer7. The Phase I/II trial described by Mease, et al in this issue of The Journal8 is thus very much to be welcomed. Not only does it greatly increase the number of subjects who have received gene therapy for arthritis, but it is also the first trial to address efficacy in a substantial fashion. Although there are several different strategies for using genes as therapeutic agents in arthritis, by far the most progress has been made with the approach of delivering genes locally to individual diseased joints2,3. There are a number of reasons for this. Not only was it the first arthritis gene therapy strategy to be proposed1, but also, by enabling sustained, endogenous, intraarticular synthesis of therapeutic gene products in selected joints, local delivery achieves something that no other technology can accomplish. Moreover, expressing the gene product intraarticularly minimizes exposure of non-target sites, thereby reducing the potential for unwanted side effects. The smaller requirements of local, rather than systemic, treatment also lower costs, especially as a successful gene therapy will require infrequent redosing. The burden of treating multiple joints individually in patients with rheumatoid arthritis (RA) may be less than first thought, following the discovery that the genetic treatment of just one joint in animals with polyarticular disease secures improvement in additional joints on the same individual9. The degree to which suppression of intraarticular disease mitigates extraarticular manifestations of RA remains to be determined. ******************************************** Read the full editorial here: http://jrheum.org/content/37/4/683.full Not an MD Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 9, 2010 Report Share Posted April 9, 2010 Kate, I am also still disturbed by that case. Not good. Not an MD On Thu, Apr 8, 2010 at 7:36 PM, Kate Fair <kalfoley@...> wrote: > I'd like to be hopeful, but I'm still creeped out by that death a few yrs back. Kate f Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 9, 2010 Report Share Posted April 9, 2010 What case? Can anyone enlighten me?  TIA, Sheryl From: <Rheumatoid.Arthritis.Support@...> Subject: Re: [ ] EDITORIAL - Arthritis gene therapy trials reach Phase II Date: Friday, April 9, 2010, 7:13 AM  Kate, I am also still disturbed by that case. Not good. Not an MD Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 9, 2010 Report Share Posted April 9, 2010 Sheryl, Kate and I are talking about the unfortunate death of RA patient Jolee Mohr in a gene therapy trial. Here are some related articles: http://www.wired.com/medtech/genetics/news/2007/08/gene_therapy http://www.wired.com/wiredscience/2007/11/tests-clear-gen/ http://www.bioethics.net/articles.php?viewCat=2 & articleId=202 If you search on her name, you will find many more articles related to the case. Not an MD On Fri, Apr 9, 2010 at 9:40 AM, Sheryl <Arrow31298@...> wrote: > What case? Can anyone enlighten me? > > TIA, > > > Sheryl Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 9, 2010 Report Share Posted April 9, 2010 Hi ,  Thanks for the links. How tragic and scary. Sheryl From: <Rheumatoid.Arthritis.Support@...> Subject: Re: [ ] EDITORIAL - Arthritis gene therapy trials reach Phase II Date: Friday, April 9, 2010, 6:03 PM  Sheryl, Kate and I are talking about the unfortunate death of RA patient Jolee Mohr in a gene therapy trial. Here are some related articles: http://www.wired. com/medtech/ genetics/ news/2007/ 08/gene_therapy http://www.wired. com/wiredscience /2007/11/ tests-clear- gen/ http://www.bioethic s.net/articles. php?viewCat= 2 & articleId= 202 If you search on her name, you will find many more articles related to the case. Not an MD Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.